RecallDepth
Class II Terminated

Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
December 29, 2021
Posted
February 2, 2022
Recall Number
D-0450-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
792 bottles
Firm Location
East Windsor, NJ, United States

Reason for Recall

Superpotent and Failed Tablet/Capsule Specifications

Distribution

Nationwide in the US

Lot / Code Info

Batch # PF4520028B & PF4520028A, Exp. Date 11/2022

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls